Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 10—October 2010
Dispatch

Epidemiology of Human Parvovirus 4 Infection in Sub-Saharan Africa

Colin P. Sharp, Marion Vermeulen, Yacouba K. Nébié, Cyrille F. Djoko, Matthew LeBreton, Ubald Tamoufe, Anne W. Rimoin, Patrick K. Kayembe, Jean K. Carr, Annabelle Servant-Delmas, Syria Laperche, G.L. Abby Harrison, Oliver G. Pybus, Eric Delwart, Nathan D. Wolfe, Andrew Saville, Jean-Jacques Lefrère, and Peter SimmondsComments to Author 
Author affiliations: Author affiliations: University of Edinburgh, Edinburgh, Scotland (C.P. Sharp, P. Simmonds); South African National Blood Service, Weltevreden Park, South Africa (M. Vermeulen, A. Saville); Centre National de Transfusion Sanguine, Ouagadougou, Burkina Faso (Y. Nébié); Global Viral Forecasting Initiative, Yaounde, Cameroon, and San Francisco, California, USA (C.F. Djoko, M. LeBreton, U. Tamoufe, N.D. Wolfe); University of California School of Public Health, Los Angeles, California, USA (A.W. Rimoin); Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo (P.K. Kayembe); University of Maryland School of Medicine, Baltimore, Maryland, USA (J.K. Carr); Institut National de la Transfusion Sanguine, Paris, France (A. Servant-Delmas, S. Laperche, J.-J. Lefrère); University of Oxford, Oxford, UK (G.L.A. Harrison, O.G. Pybus); Blood Systems Research Institute, San Francisco (E. Delwart); Stanford University, Stanford, California, USA (N.D. Wolfe); Centre Hospitalier Universitaire, Amiens, France (J.-J. Lefrère)

Main Article

Table

Seroprevalence of human parvovirus 4 antibodies in sub-Saharan African and control populations*

Country
 Category
 No.
 Co-infection Mean year of birth (range)
 Collection year
 PARV4 positive,
no. (%)
HIV†
 HCV‡
Burkina Faso Blood donors 167 0 0 1982 (1951–1999) 2007 62 (37.1)
Cameroon General population 238 0 0 1968 (1962–1972) 2007 59 (24.8)
Democratic Republic of the Congo Military population 221 2§ 0 1968 (1936–1986) 2007 78 (35.3)
South Africa Blood donors
(HIV-positive) 170 170 0 1976 (1945–1990) 2007 62 (36.4)
South Africa Blood donors
(HIV-negative) 180 0 0 NA 2009 8 (4.4)
United Kingdom General population 161 ND ND 1950 (1937–1977) 2005 0
France Blood donors 199 0 0 1965 (1943–1989) 2008 0

*HCV, hepatitis C virus; PARV4, human parvovirus 4; NA, not available; ND, screening not done.
†HIV-1 screening methods: South Africa, France: fourth-generation ELISA.
‡HCV screening methods: Burkina-Faso, South Africa, France: third-generation ELISA, recombinant immunoblot assay confirmation of positive results; Democratic Republic of the Congo: third-generation ELISA, exclusion of reactive samples; Cameroon: PCR-based screening, exclusion of PCR-positive samples. United Kingdom: not screened (ND), low risk background and absence of parenteral or HIV risk factors.
§1 of 2 HIV-positive samples was seropositive for PARV4.

Main Article

Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external